Using Claims Data to Assess Treatment Quality of First-Episode Psychosis

Objective:Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indica...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatric services (Washington, D.C.) Vol. 72; no. 3; pp. 247 - 253
Main Authors: Reist, Christopher, Valdes, Elise, Ren, Yingqian, Wright, Abel, Rubio, Jose M
Format: Journal Article
Language:English
Published: United States American Psychiatric Association 01-03-2021
American Psychiatric Publishing, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objective:Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization.Methods:Individuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization.Results:Data were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47–2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92–2.08) were most associated with psychiatric hospitalization.Conclusions:In most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP.
AbstractList Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization. Individuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization. Data were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47-2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92-2.08) were most associated with psychiatric hospitalization. In most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP.
OBJECTIVECoordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization. METHODSIndividuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization. RESULTSData were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47-2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92-2.08) were most associated with psychiatric hospitalization. CONCLUSIONSIn most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP.
Objective: Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization. Methods: Individuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization. Results: Data were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47–2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92–2.08) were most associated with psychiatric hospitalization. Conclusions: In most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP.
Author Ren, Yingqian
Rubio, Jose M
Wright, Abel
Reist, Christopher
Valdes, Elise
Author_xml – sequence: 1
  givenname: Christopher
  surname: Reist
  fullname: Reist, Christopher
  email: creist@uci.edu
– sequence: 2
  givenname: Elise
  surname: Valdes
  fullname: Valdes, Elise
  email: creist@uci.edu
– sequence: 3
  givenname: Yingqian
  surname: Ren
  fullname: Ren, Yingqian
  email: creist@uci.edu
– sequence: 4
  givenname: Abel
  surname: Wright
  fullname: Wright, Abel
  email: creist@uci.edu
– sequence: 5
  givenname: Jose M
  surname: Rubio
  fullname: Rubio, Jose M
  email: creist@uci.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33167819$$D View this record in MEDLINE/PubMed
BookMark eNp1kD1PwzAQhi0EgvLxA1iQJRaWlHMcf2SsCgWkSoDUzpHjOOAqiUMuGfrvCRQ6IDHdDc_z3uk9JYdNaBwhlwymjCl5a9rWT1ucxsBSAJGKAzJhQqgoVQCH4w5KRLHicEJOETcAwBSTx-SEcyaVZumEPK7RN290XhlfI70zvaF9oDNEh0hXnTN97Zqevg6m8v2WhpIufId9dN96DIWjL7i17wE9npOj0lToLn7mGVkv7lfzx2j5_PA0ny0jw6XuI6YLC0InIkl4zrV0PLextqUB0GkhOHOljAuuc8t0LEtu5TjBicI6ASY3_Izc7HLbLnwMDvus9mhdVZnGhQGzOBEpT2QKfESv_6CbMHTN-F0WC8a4UlomI8V2lO0CYufKrO18bbptxiD7qjn7qjlrR-m35tG5-kke8toVe-O31xGY7oBvd3_2_8RPIRSJGw
CitedBy_id crossref_primary_10_1176_appi_ps_72305
crossref_primary_10_1002_pcn5_13
crossref_primary_10_7759_cureus_39488
crossref_primary_10_1016_j_biopsych_2024_06_026
crossref_primary_10_1176_appi_ps_202100133
Cites_doi 10.1176/appi.ajp.2011.10081224
10.1176/appi.ps.201300001
10.1093/schbul/sbp129
10.4088/JCP.10m06497
10.2337/diacare.27.2.596
10.1016/j.psychres.2018.04.002
10.1093/oxfordjournals.schbul.a033303
10.1001/jamapsychiatry.2016.0538
10.1001/jamapsychiatry.2018.0623
10.1176/appi.ajp.2014.13101355
10.1192/bjp.bp.109.074526
10.1176/appi.ajp.2015.15050632
10.1001/archpsyc.56.3.241
10.4088/JCP.14m09289
10.1016/j.eurpsy.2005.05.015
10.1093/schbul/sbv224
10.1016/j.schres.2015.11.016
10.1176/appi.ajp.2018.17091001
10.1093/schbul/sbp116
10.1176/appi.ps.201400413
10.1001/jamapsychiatry.2015.0270
10.1097/NMD.0b013e31818ee231
10.1001/jama.282.15.1458
10.1056/NEJMoa1203241
10.1001/jamapsychiatry.2017.1322
10.1093/schbul/sbn138
ContentType Journal Article
Copyright Copyright © 2021 by the American Psychiatric Association 2021
Copyright American Psychiatric Publishing, Inc. Mar 2021
Copyright_xml – notice: Copyright © 2021 by the American Psychiatric Association 2021
– notice: Copyright American Psychiatric Publishing, Inc. Mar 2021
DBID NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1176/appi.ps.201900595
DatabaseName PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)

DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1557-9700
EndPage 253
ExternalDocumentID 10_1176_appi_ps_201900595
33167819
10.1176/appi.ps.201900595
Genre Journal Article
GroupedDBID -
123
1AW
1HT
1QT
29P
5RE
85S
AAPBV
AAWTL
ABFLS
ABIVO
ACHQT
ACNCT
ACVYA
ADACO
ADBBV
AENEX
AHMBA
ALMA_UNASSIGNED_HOLDINGS
B-7
BAJDF
BAWUL
CS3
DIK
DU5
E3Z
EBS
F5P
FH7
G0H
HZ
H~9
O0-
P2P
PQEST
PQQKQ
RAY
RYA
SJN
TWZ
UHB
WOQ
X
X4V
XHC
XZL
YZZ
ZA5
---
-~X
..I
18M
2WC
4.4
8R4
8R5
AAIKC
AAMNW
AAWTO
ACGFO
AGHSJ
EX3
GX1
H13
HZ~
NPM
OK1
OMB
OMG
PCD
Q2X
TR2
USG
V62
VVN
W8F
WOW
XSW
YSK
Z0I
ZVN
AAYXX
CITATION
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-a368t-18dc05845443b386e3bc28cfa0089d531ef62d38bc1826f3c61820e5dce50aba3
ISSN 1075-2730
IngestDate Fri Aug 16 21:53:59 EDT 2024
Fri Nov 22 18:37:51 EST 2024
Wed Nov 20 13:33:38 EST 2024
Sat Sep 28 08:35:13 EDT 2024
Mon Mar 01 05:13:58 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords treatment
psychoses
treatment guidelines
first episode psychosis
population health
quality
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a368t-18dc05845443b386e3bc28cfa0089d531ef62d38bc1826f3c61820e5dce50aba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 33167819
PQID 2511377864
PQPubID 41485
PageCount 7
ParticipantIDs proquest_miscellaneous_2459346903
proquest_journals_2511377864
crossref_primary_10_1176_appi_ps_201900595
pubmed_primary_33167819
appi_journals_10_1176_appi_ps_201900595
ProviderPackageCode RAY
RYA
X4V
1QT
BAJDF
G0H
PublicationCentury 2000
PublicationDate 20210301
2021-Mar-01
2021-03-01
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 20210301
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Arlington
PublicationTitle Psychiatric services (Washington, D.C.)
PublicationTitleAlternate Psychiatr Serv
PublicationYear 2021
Publisher American Psychiatric Association
American Psychiatric Publishing, Inc
Publisher_xml – name: American Psychiatric Association
– name: American Psychiatric Publishing, Inc
References Alvir, JMJ 1999; 56
Niv, N 2010; 36
Penn, DL 2015; 66
Kelly, DL 2010; 36
Cabana, MD 1999; 282
Schooler, NR 2016; 173
Parker, AG 2011; 37
Tanskanen, A 2018; 175
Susser, E 2020; 46
Alvarez-Jiménez, M 2011; 37
Marcy, P 2015; 76
Addington, J 2015; 66
Robinson, DG 2015; 172
John, M 2015; 172
Taipale, H 2018; 175
Premkumar, P 2010; 197
Rand, CS 1999; 282
Kane, JM 2015; 76
Colizzi, M 2016; 170
Schooler, NR 2015; 172
Mittendorfer-Rutz, E 2017; 74
Subotnik, KL 2015; 72
Leslie, D 2016; 42
Majak, M 2017; 74
Haukka, J 2011; 168
Caffery, E 2014; 65
Campagna, EJ 2016; 73
Ni, Q 2012; 73
Leclerc, C 2009; 196
Casaus, LR 2015; 72
Tiihonen, J 2011; 168
Robinson, DG 2016; 173
Mueser, KT 2015; 66
Barrett, A 2014; 65
Patel, U 2012; 73
Carra, E 2016; 170
Sint, K 2016; 42
Kendall, T 2010; 197
Powe, NR 1999; 282
Young, AS 2010; 36
Kouvaras, S 2018; 264
Kelly, BD 2006; 21
Zetterqvist, J 2012; 367
Nterian, Z 2018; 264
van der Ven, E 2020; 46
Rosenheck, R 2016; 42
Lecomte, T 2009; 196
Cohen, AN 2010; 36
Halldner, L 2012; 367
Woerner, MG 1999; 56
Galling, B 2018; 75
Buchanan, RW 2010; 36
Hickling, LM 2018; 264
Berkowitz, RL 2012; 73
Clarke, M 2006; 21
Lichtenstein, P 2012; 367
Morrato, EH 2016; 73
Bird, V 2010; 197
Taylor, M 2011; 168
Kreyenbuhl, J 2010; 36
Hetrick, SE 2011; 37
Kane, JM 2016; 173
Gilmer, TP 2020; 46
Brown, JD 2014; 65
Tiihonen, J 2018; 175
Corbiere, M 2009; 196
Steinwachs, DM 1998; 24
Pawar, A 2018; 75
Brewer, SE 2016; 73
Fraietta, S 2016; 170
Correll, CU 2018; 75
Kamali, M 2006; 21
Tiihonen, J 2017; 74
Robinson, D 1999; 56
Ventura, J 2015; 72
Lehman, AF 1998; 24
Schooler, NR 2015; 76
B20
B21
B22
B23
B24
B25
B26
B27
B28
Gilmer TP (B11) 2020; 46
B10
B12
B13
B14
B15
B16
B17
B18
B19
B1
B2
B3
B4
B5
B6
B7
B8
B9
References_xml – volume: 46
  start-page: 91
  year: 2020
  end-page: 97
  article-title: Service use following first-episode schizophrenia among commercially insured youth
  publication-title: Schizophr Bull
  contributor:
    fullname: Gilmer, TP
– volume: 168
  start-page: 603
  year: 2011
  end-page: 609
  article-title: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Haukka, J
– volume: 56
  start-page: 241
  year: 1999
  end-page: 247
  article-title: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
  publication-title: Arch Gen Psychiatry
  contributor:
    fullname: Alvir, JMJ
– volume: 65
  start-page: 121
  year: 2014
  end-page: 124
  article-title: State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia
  publication-title: Psychiatr Serv
  contributor:
    fullname: Brown, JD
– volume: 36
  start-page: 732
  year: 2010
  end-page: 739
  article-title: The appropriateness of routine medication treatment for schizophrenia
  publication-title: Schizophr Bull
  contributor:
    fullname: Young, AS
– volume: 282
  start-page: 1458
  year: 1999
  end-page: 1465
  article-title: Why don’t physicians follow clinical practice guidelines? A framework for improvement
  publication-title: JAMA
  contributor:
    fullname: Cabana, MD
– volume: 282
  start-page: 1458
  year: 1999
  end-page: 1465
  article-title: Why don’t physicians follow clinical practice guidelines? A framework for improvement
  publication-title: JAMA
  contributor:
    fullname: Powe, NR
– volume: 73
  start-page: 498
  year: 2012
  end-page: 503
  article-title: The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Ni, Q
– volume: 264
  start-page: 151
  year: 2018
  end-page: 154
  article-title: Non-adherence to antipsychotic medication in first-episode psychosis patients
  publication-title: Psychiatry Res
  contributor:
    fullname: Kouvaras, S
– volume: 170
  start-page: 311
  year: 2016
  end-page: 317
  article-title: Substance use, medication adherence and outcome one year following a first episode of psychosis
  publication-title: Schizophr Res
  contributor:
    fullname: Carra, E
– volume: 37
  start-page: 619
  year: 2011
  end-page: 630
  article-title: Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis
  publication-title: Schizophr Bull
  contributor:
    fullname: Hetrick, SE
– volume: 175
  start-page: 765
  year: 2018
  end-page: 773
  article-title: 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Tiihonen, J
– volume: 75
  start-page: 555
  year: 2018
  end-page: 565
  article-title: Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Galling, B
– volume: 197
  start-page: 350
  year: 2010
  end-page: 356
  article-title: Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review
  publication-title: Br J Psychiatry
  contributor:
    fullname: Premkumar, P
– volume: 37
  start-page: 619
  year: 2011
  end-page: 630
  article-title: Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis
  publication-title: Schizophr Bull
  contributor:
    fullname: Parker, AG
– volume: 66
  start-page: 680
  year: 2015
  end-page: 690
  article-title: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components
  publication-title: Psychiatr Serv
  contributor:
    fullname: Addington, J
– volume: 36
  start-page: 71
  year: 2010
  end-page: 93
  article-title: The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements
  publication-title: Schizophr Bull
  contributor:
    fullname: Buchanan, RW
– volume: 21
  start-page: 29
  year: 2006
  end-page: 33
  article-title: A prospective evaluation of adherence to medication in first episode schizophrenia
  publication-title: Eur Psychiatry
  contributor:
    fullname: Clarke, M
– volume: 196
  start-page: 866
  year: 2009
  end-page: 875
  article-title: Group cognitive behavioral therapy or social skills training for individuals with a recent onset of psychosis: results of a randomized controlled trial
  publication-title: J Nerv Ment Dis
  contributor:
    fullname: Leclerc, C
– volume: 36
  start-page: 732
  year: 2010
  end-page: 739
  article-title: The appropriateness of routine medication treatment for schizophrenia
  publication-title: Schizophr Bull
  contributor:
    fullname: Cohen, AN
– volume: 21
  start-page: 29
  year: 2006
  end-page: 33
  article-title: A prospective evaluation of adherence to medication in first episode schizophrenia
  publication-title: Eur Psychiatry
  contributor:
    fullname: Kelly, BD
– volume: 74
  start-page: 686
  year: 2017
  end-page: 693
  article-title: Real-world effectiveness of anti-psychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Majak, M
– volume: 42
  start-page: 896
  year: 2016
  end-page: 906
  article-title: Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program
  publication-title: Schizophr Bull
  contributor:
    fullname: Sint, K
– volume: 175
  start-page: 765
  year: 2018
  end-page: 773
  article-title: 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Tanskanen, A
– volume: 56
  start-page: 241
  year: 1999
  end-page: 247
  article-title: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
  publication-title: Arch Gen Psychiatry
  contributor:
    fullname: Robinson, D
– volume: 24
  start-page: 11
  year: 1998
  end-page: 32
  article-title: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey
  publication-title: Schizophr Bull
  contributor:
    fullname: Lehman, AF
– volume: 56
  start-page: 241
  year: 1999
  end-page: 247
  article-title: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
  publication-title: Arch Gen Psychiatry
  contributor:
    fullname: Woerner, MG
– volume: 196
  start-page: 866
  year: 2009
  end-page: 875
  article-title: Group cognitive behavioral therapy or social skills training for individuals with a recent onset of psychosis: results of a randomized controlled trial
  publication-title: J Nerv Ment Dis
  contributor:
    fullname: Lecomte, T
– volume: 173
  start-page: 362
  year: 2016
  end-page: 372
  article-title: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program
  publication-title: Am J Psychiatry
  contributor:
    fullname: Robinson, DG
– volume: 37
  start-page: 619
  year: 2011
  end-page: 630
  article-title: Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis
  publication-title: Schizophr Bull
  contributor:
    fullname: Alvarez-Jiménez, M
– volume: 367
  start-page: 2006
  year: 2012
  end-page: 2014
  article-title: Medication for attention deficit-hyperactivity disorder and criminality
  publication-title: N Engl J Med
  contributor:
    fullname: Halldner, L
– volume: 367
  start-page: 2006
  year: 2012
  end-page: 2014
  article-title: Medication for attention deficit-hyperactivity disorder and criminality
  publication-title: N Engl J Med
  contributor:
    fullname: Zetterqvist, J
– volume: 76
  start-page: 240
  year: 2015
  end-page: 246
  article-title: The RAISE Early Treatment Program for first-episode psychosis: background, rationale, and study design
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Schooler, NR
– volume: 172
  start-page: 237
  year: 2015
  end-page: 248
  article-title: Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study
  publication-title: Am J Psychiatry
  contributor:
    fullname: Schooler, NR
– volume: 24
  start-page: 11
  year: 1998
  end-page: 32
  article-title: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey
  publication-title: Schizophr Bull
  contributor:
    fullname: Steinwachs, DM
– volume: 65
  start-page: 121
  year: 2014
  end-page: 124
  article-title: State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia
  publication-title: Psychiatr Serv
  contributor:
    fullname: Caffery, E
– volume: 73
  start-page: 721
  year: 2016
  end-page: 730
  article-title: Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health goals
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Brewer, SE
– volume: 72
  start-page: 822
  year: 2015
  end-page: 829
  article-title: Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Casaus, LR
– volume: 367
  start-page: 2006
  year: 2012
  end-page: 2014
  article-title: Medication for attention deficit-hyperactivity disorder and criminality
  publication-title: N Engl J Med
  contributor:
    fullname: Lichtenstein, P
– volume: 73
  start-page: 498
  year: 2012
  end-page: 503
  article-title: The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Patel, U
– volume: 75
  start-page: 555
  year: 2018
  end-page: 565
  article-title: Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Pawar, A
– volume: 36
  start-page: 71
  year: 2010
  end-page: 93
  article-title: The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements
  publication-title: Schizophr Bull
  contributor:
    fullname: Kelly, DL
– volume: 73
  start-page: 721
  year: 2016
  end-page: 730
  article-title: Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health goals
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Campagna, EJ
– volume: 65
  start-page: 121
  year: 2014
  end-page: 124
  article-title: State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia
  publication-title: Psychiatr Serv
  contributor:
    fullname: Barrett, A
– volume: 42
  start-page: 896
  year: 2016
  end-page: 906
  article-title: Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program
  publication-title: Schizophr Bull
  contributor:
    fullname: Rosenheck, R
– volume: 170
  start-page: 311
  year: 2016
  end-page: 317
  article-title: Substance use, medication adherence and outcome one year following a first episode of psychosis
  publication-title: Schizophr Res
  contributor:
    fullname: Colizzi, M
– volume: 73
  start-page: 498
  year: 2012
  end-page: 503
  article-title: The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Berkowitz, RL
– volume: 172
  start-page: 237
  year: 2015
  end-page: 248
  article-title: Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study
  publication-title: Am J Psychiatry
  contributor:
    fullname: John, M
– volume: 36
  start-page: 71
  year: 2010
  end-page: 93
  article-title: The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements
  publication-title: Schizophr Bull
  contributor:
    fullname: Kreyenbuhl, J
– volume: 73
  start-page: 721
  year: 2016
  end-page: 730
  article-title: Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health goals
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Morrato, EH
– volume: 66
  start-page: 680
  year: 2015
  end-page: 690
  article-title: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components
  publication-title: Psychiatr Serv
  contributor:
    fullname: Mueser, KT
– volume: 264
  start-page: 151
  year: 2018
  end-page: 154
  article-title: Non-adherence to antipsychotic medication in first-episode psychosis patients
  publication-title: Psychiatry Res
  contributor:
    fullname: Hickling, LM
– volume: 72
  start-page: 822
  year: 2015
  end-page: 829
  article-title: Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Subotnik, KL
– volume: 76
  start-page: 240
  year: 2015
  end-page: 246
  article-title: The RAISE Early Treatment Program for first-episode psychosis: background, rationale, and study design
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Kane, JM
– volume: 168
  start-page: 603
  year: 2011
  end-page: 609
  article-title: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Taylor, M
– volume: 264
  start-page: 151
  year: 2018
  end-page: 154
  article-title: Non-adherence to antipsychotic medication in first-episode psychosis patients
  publication-title: Psychiatry Res
  contributor:
    fullname: Nterian, Z
– volume: 75
  start-page: 555
  year: 2018
  end-page: 565
  article-title: Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Correll, CU
– volume: 74
  start-page: 686
  year: 2017
  end-page: 693
  article-title: Real-world effectiveness of anti-psychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Mittendorfer-Rutz, E
– volume: 172
  start-page: 237
  year: 2015
  end-page: 248
  article-title: Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study
  publication-title: Am J Psychiatry
  contributor:
    fullname: Robinson, DG
– volume: 173
  start-page: 362
  year: 2016
  end-page: 372
  article-title: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program
  publication-title: Am J Psychiatry
  contributor:
    fullname: Schooler, NR
– volume: 76
  start-page: 240
  year: 2015
  end-page: 246
  article-title: The RAISE Early Treatment Program for first-episode psychosis: background, rationale, and study design
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Marcy, P
– volume: 42
  start-page: 896
  year: 2016
  end-page: 906
  article-title: Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program
  publication-title: Schizophr Bull
  contributor:
    fullname: Leslie, D
– volume: 74
  start-page: 686
  year: 2017
  end-page: 693
  article-title: Real-world effectiveness of anti-psychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Tiihonen, J
– volume: 196
  start-page: 866
  year: 2009
  end-page: 875
  article-title: Group cognitive behavioral therapy or social skills training for individuals with a recent onset of psychosis: results of a randomized controlled trial
  publication-title: J Nerv Ment Dis
  contributor:
    fullname: Corbiere, M
– volume: 197
  start-page: 350
  year: 2010
  end-page: 356
  article-title: Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review
  publication-title: Br J Psychiatry
  contributor:
    fullname: Kendall, T
– volume: 173
  start-page: 362
  year: 2016
  end-page: 372
  article-title: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program
  publication-title: Am J Psychiatry
  contributor:
    fullname: Kane, JM
– volume: 46
  start-page: 91
  year: 2020
  end-page: 97
  article-title: Service use following first-episode schizophrenia among commercially insured youth
  publication-title: Schizophr Bull
  contributor:
    fullname: Susser, E
– volume: 175
  start-page: 765
  year: 2018
  end-page: 773
  article-title: 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Taipale, H
– volume: 21
  start-page: 29
  year: 2006
  end-page: 33
  article-title: A prospective evaluation of adherence to medication in first episode schizophrenia
  publication-title: Eur Psychiatry
  contributor:
    fullname: Kamali, M
– volume: 46
  start-page: 91
  year: 2020
  end-page: 97
  article-title: Service use following first-episode schizophrenia among commercially insured youth
  publication-title: Schizophr Bull
  contributor:
    fullname: van der Ven, E
– volume: 72
  start-page: 822
  year: 2015
  end-page: 829
  article-title: Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Ventura, J
– volume: 168
  start-page: 603
  year: 2011
  end-page: 609
  article-title: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
  publication-title: Am J Psychiatry
  contributor:
    fullname: Tiihonen, J
– volume: 36
  start-page: 732
  year: 2010
  end-page: 739
  article-title: The appropriateness of routine medication treatment for schizophrenia
  publication-title: Schizophr Bull
  contributor:
    fullname: Niv, N
– volume: 282
  start-page: 1458
  year: 1999
  end-page: 1465
  article-title: Why don’t physicians follow clinical practice guidelines? A framework for improvement
  publication-title: JAMA
  contributor:
    fullname: Rand, CS
– volume: 170
  start-page: 311
  year: 2016
  end-page: 317
  article-title: Substance use, medication adherence and outcome one year following a first episode of psychosis
  publication-title: Schizophr Res
  contributor:
    fullname: Fraietta, S
– volume: 66
  start-page: 680
  year: 2015
  end-page: 690
  article-title: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components
  publication-title: Psychiatr Serv
  contributor:
    fullname: Penn, DL
– volume: 197
  start-page: 350
  year: 2010
  end-page: 356
  article-title: Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review
  publication-title: Br J Psychiatry
  contributor:
    fullname: Bird, V
– ident: B12
– ident: B16
  doi: 10.1176/appi.ajp.2011.10081224
– ident: B20
  doi: 10.1176/appi.ps.201300001
– ident: B1
  doi: 10.1093/schbul/sbp129
– ident: B5
  doi: 10.4088/JCP.10m06497
– ident: B25
  doi: 10.2337/diacare.27.2.596
– ident: B18
  doi: 10.1016/j.psychres.2018.04.002
– ident: B8
  doi: 10.1093/oxfordjournals.schbul.a033303
– ident: B26
  doi: 10.1001/jamapsychiatry.2016.0538
– ident: B4
  doi: 10.1001/jamapsychiatry.2018.0623
– ident: B10
  doi: 10.1176/appi.ajp.2014.13101355
– ident: B2
  doi: 10.1192/bjp.bp.109.074526
– ident: B3
  doi: 10.1176/appi.ajp.2015.15050632
– ident: B21
  doi: 10.1001/archpsyc.56.3.241
– ident: B6
  doi: 10.4088/JCP.14m09289
– ident: B17
  doi: 10.1016/j.eurpsy.2005.05.015
– ident: B28
  doi: 10.1093/schbul/sbv224
– ident: B19
  doi: 10.1016/j.schres.2015.11.016
– ident: B22
  doi: 10.1176/appi.ajp.2018.17091001
– volume: 46
  start-page: 91
  year: 2020
  ident: B11
  publication-title: Schizophr Bull
  contributor:
    fullname: Gilmer TP
– ident: B24
  doi: 10.1093/schbul/sbp116
– ident: B13
  doi: 10.1176/appi.ps.201400413
– ident: B23
  doi: 10.1001/jamapsychiatry.2015.0270
– ident: B27
  doi: 10.1097/NMD.0b013e31818ee231
– ident: B9
  doi: 10.1001/jama.282.15.1458
– ident: B15
  doi: 10.1056/NEJMoa1203241
– ident: B14
  doi: 10.1001/jamapsychiatry.2017.1322
– ident: B7
  doi: 10.1093/schbul/sbn138
SSID ssj0001716
Score 2.4188735
Snippet Objective:Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual...
Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care...
Objective: Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the...
OBJECTIVECoordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual...
SourceID proquest
crossref
pubmed
appi
SourceType Aggregation Database
Index Database
Publisher
StartPage 247
SubjectTerms Antipsychotics
Best practice
Health services utilization
Medicaid
Psychosis
Quality of care
Title Using Claims Data to Assess Treatment Quality of First-Episode Psychosis
URI http://dx.doi.org/10.1176/appi.ps.201900595
https://www.ncbi.nlm.nih.gov/pubmed/33167819
https://www.proquest.com/docview/2511377864
https://search.proquest.com/docview/2459346903
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdp9zIYo_ts2m5oMBisOEss-euxpA4ZK93o3NE9GVmSwZDF3pz8_72z5I8SWraHvRgjG9nofjr97nR3IuQ954IxrmCm-Vo7PFTcESqPHBZpOZMhHjKCruzl9-DyJjyPeTwatQeT9G3_VdLQBrLGzNl_kHbXKTTAPcgcriB1uP6V3E0MwHwlil81yHQjkF2ard3TpIsqN6Uzmt31RQEE0Imroi6VtgqxLuoha_3WhkQX8rS2ygWpaXcSk1Fdk_lk4Fi40oXJJxnUL2if_RArZRMhVkW_PXRldOBP6PP3ALa9B-EssxH-1k_hDgK1BqkBrWK3v9y72nYiP8EsxWQ5u2mjrXb2AicKptOh-g7cAUzZUBebUp67a0TQFEeuqmJSYcF2oETAMb1-QWyDAC6_povri4s0iW-SPfLIBVXWGO2fv3RrPRYbMlGt5mftvjl84tPOB2DRx7a7BOgeq6ZhN8kBeWrNEnpm8PSMjPT6OXlifLrUpKq9IMsGW9RgiyK26KakBlu0wxa12KJlTu9gi3bYekmuF3EyXzr2JA5HMD_cOLNQySlQVSyWmDGY1iyTbihzAQwyUqDGde67ioWZRHM1Z9LHcwG0p6T2piIT7BXZX5drfUioH4Uq8_hMyybEOI8EczWQdBWidcuCMfmAo5TaKVWnjZUa-GnTWtVpN55j8rEdyLQypVkeevmkHeq-azSvGRZQ5GPyrnsM-hU3zcRal1t4h3sRQx8SG5PXRkTd1xiWkQBKffRw58fkcT8hTsj-5s9WvyF7tdq-bdB0C3KjnT4
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+Claims+Data+to+Assess+Treatment+Quality+of+First-Episode+Psychosis&rft.jtitle=Psychiatric+services+%28Washington%2C+D.C.%29&rft.au=Reist%2C+Christopher&rft.au=Valdes%2C+Elise&rft.au=Ren%2C+Yingqian&rft.au=Wright%2C+Abel&rft.date=2021-03-01&rft.pub=American+Psychiatric+Publishing%2C+Inc&rft.issn=1075-2730&rft.eissn=1557-9700&rft.volume=72&rft.issue=3&rft.spage=247&rft_id=info:doi/10.1176%2Fappi.ps.201900595&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1075-2730&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1075-2730&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1075-2730&client=summon